Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 10/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27250620 | 0.96 | ALDH1A1 (0.41) | ALDH1A1RECQLPPARDBACE1MMP3 | |
| SCHEMBL27250594 | 0.92 | ALDH1A1 (0.40) | ALDH1A1RECQLPPARDBACE1MMP3 | |
| SCHEMBL27250673 | 0.90 | ALDH1A1 (0.38) | ALDH1A1RECQLPPARDBACE1MMP3 | |
| SCHEMBL27250621 | 0.90 | PPARD (0.40) | ALDH1A1RECQLPPARDBACE1MMP3 | |
| SCHEMBL22216932 | 0.85 | BACE1 (0.43) | PPARDBACE1MMP3LMNAKMT2A | |
| SCHEMBL27251461 | 0.85 | PPARD (0.38) | ALDH1A1PPARDBACE1MMP3NPC1 | |
| SCHEMBL22217125 | 0.85 | BACE1 (0.48) | RECQLPPARDBACE1NPC1LMNA | |
| SCHEMBL27251519 | 0.83 | PPARD (0.41) | ALDH1A1PPARDBACE1NPC1LMNA | |
| SCHEMBL27250652 | 0.80 | PPARD (0.36) | PPARDBACE1MMP3NPC1USP2 | |
| SCHEMBL27250650 | 0.80 | PPARD (0.40) | PPARDNPC1USP2PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | STEPAN COMPANY | 2024-06-27 | — | — | US | disclosed |
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | STEPAN COMPANY | 2024-06-27 | — | — | US | disclosed |
| US-20200223988-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | STEPAN COMPANY | 2020-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200223988-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | TYR, PAOX, NAPEPLD | ALDH1A1 440/4885RECQL 915/4885PPARD 566/4885 |
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | TYR, PAOX, NAPEPLD | ALDH1A1 440/4885RECQL 915/4885PPARD 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.